Procalcitonin to Guide Antibacterial Prescribing in Patients Hospitalised with COVID-19
Antibacterial prescribing in patients presenting with COVID-19 remains discordant to rates of bacterial co-infection. Implementing diagnostic tests to exclude bacterial infection may aid reduction in antibacterial prescribing. (1) Method: A retrospective observational analysis was undertaken of all...
Saved in:
Main Authors: | Stephen Hughes (Author), Nabeela Mughal (Author), Luke S. P. Moore (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Prognostic Models: A Pro-con Debate for Machine Learning vs. Traditional Statistics
by: Ahmed Al-Hindawi, et al.
Published: (2021) -
Prognostic Modeling of COVID-19 Using Artificial Intelligence in the United Kingdom: Model Development and Validation
by: Abdulaal, Ahmed, et al.
Published: (2020) -
Comparison of prescribing criteria in hospitalised Australian elderly
by: Pattanaworasate W, et al.
Published: (2010) -
PROCALCITONIN AS ANTIMICROBIAL MANAGEMENT TOOL IN COVID-19 PATIENTS
by: Maria Helena Lenardt, et al.
Published: (2023) -
Procalcitonin Serum Level in the Admitted COVID-19 Patients
by: Somayeh Sheidaei, et al.
Published: (2023)